Cargando…
Outcomes of end‐stage renal disease patients in the PROCESS trial
OBJECTIVE: Intravenous fluid administration is a main component of sepsis therapy, but physicians are cautious about giving fluids to end‐stage renal disease (ESRD) patients out of concern for causing volume overload. We compared the outcomes of septic shock patients with and without ESRD and evalua...
Autores principales: | Huebinger, Ryan M., Walia, Shabana, Yealy, Donald M., Kellum, John A., Huang, David T., Wang, Henry E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813517/ https://www.ncbi.nlm.nih.gov/pubmed/33506231 http://dx.doi.org/10.1002/emp2.12358 |
Ejemplares similares
-
Reversible Choreoathetosis in a Patient with End-stage Renal Disease from Administration of Ceftriaxone
por: Tan, Mei Ling, et al.
Publicado: (2019) -
The Impact of COVID-19 Infection Control Measures on End-Stage Renal Disease Patients in a Community Hemodialysis Setting
por: Khan, Behram A, et al.
Publicado: (2023) -
Trends and Outcomes of Hospitalized Influenza Patients With End-Stage Kidney Disease: Insights From the National Inpatient Sample 2010–2019
por: Zou, Guangchen, et al.
Publicado: (2022) -
End-Stage Renal Disease Patients on Chronic Hemodialysis Fare Better With COVID-19: A Retrospective Cohort Study From the New York Metropolitan Region
por: Naaraayan, Ashutossh, et al.
Publicado: (2020) -
Evolution of Public Responses to COVID-19: Comparing Changes in People's Emotions, Behaviors, and Precautions at the Onset and End Stage of the Pandemic
por: Barkay, Orçun, et al.
Publicado: (2023)